The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
20210590: Amy Adams Strunk; KSA Industries, Inc
20210593: PEP VIII Intermediate 7 L.P; McCarthy Capital Fund VI, L.P.
20210594: George W. LeMaitre; LeMaitre Vascular, Inc.
20210595: Golden Gate Capital Opportunity Fund, L.P.; TWAS Topco, L.P.
20210596: Legrand S.A.; AMCO Optics AIV, L.P.
20210598: Beth Trice; Tidal Group LLC
20210601: Beth Trice; Scott Blackstock
20210603: PPG Industries, Inc.; Olympus Growth Fund VI, L.P.
20210605: Vector Capital V, L.P.; Mood Media LLC
20210613: NovaQuest Private Equity Fund I, L.P.; CoreRX, Inc.
20210616: FedEx Corporation; ShopRunner, Inc.
20210672: Athene Holding Ltd.; Hertz Global Holdings, Inc.
16 CFR Part 432: Trade Regulation Rule Relating to Power Output Claims for Amplifiers Utilized in Home Entertainment Products
Agency Information Collection Activities; Submission for OMB Review; Comment Request (Business Opportunity Rule)
Stryker and Wright Medical, In the Matter of
The Federal Trade Commission required medical device companies Stryker Corp. and Wright Medical Group N.V. to divest all assets related to Stryker’s total ankle replacements and finger joint implant products to remedy concerns, as alleged in the complaint, that Stryker’s proposed $4 billion acquisition of Wright would harm competition in these two markets. Under the consent order, Stryker and Wright must divest all assets associated with Stryker’s total ankle replacements and finger joint implants to DJO Global, allowing it to become an independent, viable, and effective competitor in these markets. After a period for public comment, the Commission issued its final order on December 11, 2020.